Analyzing RNA-Seq data from Chlamydia with super broad transcriptomic activation: challenges, solutions, and...

Area of Science:

• Microbiology
• Genomics
• Bioinformatics

Background:

• RNA sequencing (RNA-Seq) is crucial for transcriptome analysis but faces limitations with specific biological systems.
• Standard differential expression analysis tools like DESeq2 and edgeR are ill-suited for the transcriptomes of Chlamydia spp. due to violated assumptions.
• The immediate early transcriptomes of Chlamydia spp. exhibit extensive transcriptomic activation and limited repression, challenging conventional analysis.

Purpose of the Study:

• To address the limitations of standard RNA-Seq analysis pipelines for Chlamydia spp. early infection transcriptomes.
• To develop and validate revised normalization methods for accurate gene expression analysis in scenarios with unbalanced transcriptomic dynamics.

Main Methods:

• Comparison of standard RNA-Seq analysis with revised normalization strategies incorporating chlamydial and host reads.
• Adjustment for total sequencing depth as an alternative normalization approach.
• Validation of revised methods using quantitative reverse transcription PCR (qRT-PCR).

Main Results:

• Standard analysis identified approximately 300 upregulated and 300 downregulated genes, misrepresenting actual expression trends.
• Revised normalization methods (using host reads or total sequencing depth) identified over 700 upregulated genes and fewer than 30 downregulated genes.
• qRT-PCR confirmed that adjusted approaches accurately reflect transcriptomic activation during early Chlamydia infection.

Conclusions:

• Standard RNA-Seq analysis tools are inadequate for transcriptomes with extensive activation, like Chlamydia spp. during early infection.
• Revised normalization methods provide a more accurate representation of gene expression dynamics in such systems.
• These adjusted approaches can enhance transcriptomic analysis accuracy in other biological systems with unbalanced gene expression.